Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning.
Manak MS, Varsanik JS, Hogan BJ, Whitfield MJ, Su WR, Joshi N, Steinke N, Min A, Berger D, Saphirstein RJ, Dixit G, Meyyappan T, Chu HM, Knopf KB, Albala DM, Sant GR, Chander AC.
Manak MS, et al. Among authors: saphirstein rj.
Nat Biomed Eng. 2018 Oct;2(10):761-772. doi: 10.1038/s41551-018-0285-z. Epub 2018 Sep 17.
Nat Biomed Eng. 2018.
PMID: 30854249
Free PMC article.